Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander W Wyatt

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
JAMA Oncology|September 21, 2023
Rare Genetic Drivers of Lethal Prostate CancerAlexander W Wyatt
Trends in Cancer|July 5, 2021
Technical and biological constraints on ctDNA-based genotypingCameron Herberts, Alexander W Wyatt
Urologic Oncology|December 18, 2017
Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNAElie Ritch, Alexander W Wyatt
Molecular Vision|July 31, 2009
MLGA: a cost-effective approach to the diagnosis of gene deletions in eye development anomaliesAlexander W Wyatt, Nicola Ragge
The Journal of Pathology|June 8, 2013
In Brief: Chromothripsis and cancerAlexander W Wyatt, Colin C Collins
EMBO Molecular Medicine|April 22, 2015
Targeting the adaptive molecular landscape of castration-resistant prostate cancerAlexander W Wyatt, Martin E Gleave
The Prostate|June 3, 2022
Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancerEdmond M Kwan, Alexander W Wyatt
Nature Reviews. Urology|March 20, 2021
Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancerSarah W S Ng, Alexander W Wyatt
BJU International|May 11, 2019
Molecular landscape of carcinoma invading bladder muscle: does patient age matter?Roland Seiler, Alexander W Wyatt, Peter C Black
Cancer Genetics|September 30, 2017
Clinical utility of emerging liquid biomarkers in advanced prostate cancerGillian Vandekerkhove, Kim N Chi, Alexander W Wyatt
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
JAMA Oncology|September 21, 2023
Rare Genetic Drivers of Lethal Prostate CancerAlexander W Wyatt
Trends in Cancer|July 5, 2021
Technical and biological constraints on ctDNA-based genotypingCameron Herberts, Alexander W Wyatt
Urologic Oncology|December 18, 2017
Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNAElie Ritch, Alexander W Wyatt
Molecular Vision|July 31, 2009
MLGA: a cost-effective approach to the diagnosis of gene deletions in eye development anomaliesAlexander W Wyatt, Nicola Ragge
The Journal of Pathology|June 8, 2013
In Brief: Chromothripsis and cancerAlexander W Wyatt, Colin C Collins
EMBO Molecular Medicine|April 22, 2015
Targeting the adaptive molecular landscape of castration-resistant prostate cancerAlexander W Wyatt, Martin E Gleave
The Prostate|June 3, 2022
Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancerEdmond M Kwan, Alexander W Wyatt
Nature Reviews. Urology|March 20, 2021
Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancerSarah W S Ng, Alexander W Wyatt
BJU International|May 11, 2019
Molecular landscape of carcinoma invading bladder muscle: does patient age matter?Roland Seiler, Alexander W Wyatt, Peter C Black
Cancer Genetics|September 30, 2017
Clinical utility of emerging liquid biomarkers in advanced prostate cancerGillian Vandekerkhove, Kim N Chi, Alexander W Wyatt
Pageof 14